Boiling and ready to burst as AcelRx Pharmaceuticals Inc. (ACRX) last month performance was -32.92% – Invest Chronicle

Boiling and ready to burst as AcelRx Pharmaceuticals Inc. (ACRX) last month performance was -32.92%

For the readers interested in the stock health of AcelRx Pharmaceuticals Inc. (ACRX). It is currently valued at $0.19. When the transactions were called off in the previous session, Stock hit the highs of $0.2146, after setting-off with the price of $0.2135. Company’s stock value dipped to $0.191 during the trading on the day. When the trading was stopped its value was $0.21.Recently in News on May 20, 2022, AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Global Investment Conference. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (“AcelRx”), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that Chief Executive Officer, Vince Angotti will present in-person and be available for one-on-one meetings throughout the H.C. Wainwright Global Investment Conference, to be held in person and virtually May 23-26, 2022 in Miami, FL. You can read further details here

AcelRx Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.6499 on 01/04/22, with the lowest value was $0.1600 for the same time period, recorded on 05/12/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


AcelRx Pharmaceuticals Inc. (ACRX) full year performance was -85.30%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AcelRx Pharmaceuticals Inc. shares are logging -87.48% during the 52-week period from high price, and 21.25% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.16 and $1.55.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1043662 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the AcelRx Pharmaceuticals Inc. (ACRX) recorded performance in the market was -65.37%, having the revenues showcasing -41.46% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 25.62M, as it employees total of 43 workers.

Analysts verdict on AcelRx Pharmaceuticals Inc. (ACRX)

During the last month, 0 analysts gave the AcelRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.3024, with a change in the price was noted -0.27. In a similar fashion, AcelRx Pharmaceuticals Inc. posted a movement of -57.87% for the period of last 100 days, recording 1,171,832 in trading volumes.

AcelRx Pharmaceuticals Inc. (ACRX): Technical Analysis

Raw Stochastic average of AcelRx Pharmaceuticals Inc. in the period of last 50 days is set at 22.67%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 14.00%. In the last 20 days, the company’s Stochastic %K was 22.85% and its Stochastic %D was recorded 20.23%.

Let’s take a glance in the erstwhile performances of AcelRx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -65.37%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -65.01%, alongside a downfall of -85.30% for the period of the last 12 months. The shares increased approximately by -3.58% in the 7-day charts and went up by -32.92% in the period of the last 30 days. Common stock shares were lifted by -41.46% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts